134 related articles for article (PubMed ID: 35134960)
1. Selective serotonin reuptake inhibitors associated with increased mortality risk in breast cancer patients in Northern Israel.
Fischer A; Rennert HS; Rennert G
Int J Epidemiol; 2022 Jun; 51(3):807-816. PubMed ID: 35134960
[TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study.
Busby J; Mills K; Zhang SD; Liberante FG; Cardwell CR
Breast Cancer Res; 2018 Jan; 20(1):4. PubMed ID: 29351761
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
4. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
5. A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
BMC Med; 2010 Dec; 8():90. PubMed ID: 21176215
[TBL] [Abstract][Full Text] [Related]
6. Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.
Valachis A; Garmo H; Weinman J; Fredriksson I; Ahlgren J; Sund M; Holmberg L
Breast Cancer Res Treat; 2016 Sep; 159(2):293-303. PubMed ID: 27492739
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
[TBL] [Abstract][Full Text] [Related]
8. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
9. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study.
Löppönen P; Tetri S; Juvela S; Huhtakangas J; Saloheimo P; Bode MK; Hillbom M
J Neurosurg; 2014 Jun; 120(6):1358-63. PubMed ID: 24506245
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
Front Oncol; 2012; 2():177. PubMed ID: 23227451
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder.
Chen VC; Lee MJ; Yang YH; Lu ML; Chiu WC; Dewey ME
Drug Alcohol Depend; 2021 Feb; 219():108495. PubMed ID: 33429293
[TBL] [Abstract][Full Text] [Related]
12. Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
Kwak N; Lee H; Kim BK; Yu YM; Kang HY
J Gastroenterol Hepatol; 2024 Feb; 39(2):280-288. PubMed ID: 37961007
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen.
Lash TL; Cronin-Fenton D; Ahern TP; Rosenberg CL; Lunetta KL; Silliman RA; Hamilton-Dutoit S; Garne JP; Ewertz M; Sørensen HT; Pedersen L
Acta Oncol; 2010 Apr; 49(3):305-12. PubMed ID: 20156115
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression.
Desai R; Park H; Brown JD; Mohandas R; Smith SM
Pharmacotherapy; 2022 Jun; 42(6):472-482. PubMed ID: 35478186
[TBL] [Abstract][Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
17. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants.
Salkeld E; Ferris LE; Juurlink DN
J Clin Psychopharmacol; 2008 Apr; 28(2):230-4. PubMed ID: 18344737
[TBL] [Abstract][Full Text] [Related]
18. Use of selective serotonin reuptake inhibitors antidepressants and bleeding risk in breast cosmetic surgery.
Basile FV; Basile AR; Basile VV
Aesthetic Plast Surg; 2013 Jun; 37(3):561-6. PubMed ID: 23571783
[TBL] [Abstract][Full Text] [Related]
19. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
Renoux C; Vahey S; Dell'Aniello S; Boivin JF
JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Cao TXD; Filliter C; Montastruc F; Yu OHY; Fergusson E; Rej S; Azoulay L; Renoux C
J Affect Disord; 2022 Dec; 318():231-237. PubMed ID: 36084758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
